News for PIII Stock

P3 Health Partners Announces First Quarter 2025 Results P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27 P3 Health Partners to Participate in the TD Cowen 45th Annual Health Care Conference P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction P3 Health Partners to Present at the 43rd Annual J.P. Morgan Healthcare Conference P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference P3 Health Partners to Participate in Upcoming Investor Conferences P3 Health Partners Announces Third Quarter 2024 Results P3 Health Partners Schedules Third Quarter 2024 Earnings Release and Conference Call P3 Health Partners to Present at the LD Micro Main Event XVII P3 Health Partners Names Leif Pedersen New Chief Financial Officer P3 Health Partners to Present at Upcoming Investor Conferences P3 Health Partners Announces Second Quarter 2024 Results P3 Health Partners Schedules Second Quarter 2024 Earnings Release and Conference Call P3 Health Partners Forms Strategic Partnership with Innovaccer to Drive Value-Based Care and Patient Experience P3 Health Partners to Present at Upcoming Investor Conferences P3 Health Partners Inc. Announces Approximately $42.2 Million Private Placement P3 Health Partners Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) P3 Health Partners Names Dr. Aric Coffman as CEO P3 Health Partners Announces First Quarter 2024 Results P3 Health Partners Schedules First Quarter 2024 Earnings Release and Conference Call P3 Health Partners to Present at the 23rd Annual Needham Virtual Healthcare Conference P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 P3 Health Partners to Present at the KeyBanc LifeSciences & Medtech Investor Forum P3 Health Partners to Participate in the Jefferies Value Based Healthcare Summit P3 Health Partners to Present at the TD Cowen 44th Annual Healthcare Conference P3 Health Partners to Participate in The 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024 P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference P3 Health Partners to Present at the BTIG Digital Health Forum P3 Health Partners Announces Third-Quarter and Year-to-Date 2023 Results P3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference Call P3 Health Partners to Participate in the Lake Street Best Ideas Growth Conference P3 Health Partners to Present at Wells Fargo Healthcare Conference P3 Health Partners Announces Second-Quarter 2023 Results P3 Health Partners Schedules Second-Quarter 2023 Earnings Release and Conference Call P3 Health Partners Names William Bettermann as Chief Operating Officer P3 Health Partners Announces First-Quarter 2023 Results P3 Health Partners Schedules First-Quarter 2023 Earnings Release and Conference Call P3 Health Partners Announces Fourth Quarter and Full-Year 2022 Results P3 Health Partners Inc. Announces Approximately $90 Million Private Placement P3 Health Partners Announces Date Change for Fourth-Quarter and Full-Year 2022 Earnings Call P3 Health Partners to Report Fourth-Quarter and Full-Year 2022 Financial Results on March 30 P3 Health Partners Affirms 2023 Outlook and Schedules Earnings Call for 2022 Results P3 Health Partners Executive to Present at Upcoming Investor Conferences P3 Health Partners CEO to Present at Upcoming Investor Conference P3 Health Partners Reaffirms Guidance For 2022 and Announces Guidance For 2023 P3 Health Partners to Present at the 41st Annual J.P. Morgan Healthcare Conference P3 Health Partners Names Atul Kavthekar Chief Financial Officer P3 Health Partners Provides Third-Quarter and Year-to-Date 2022 Financial Results P3 Health Partners to Present Third Quarter 2022 Financial Results P3 Health Partners Announces Participation in Credit Suisse Healthcare Conference P3 Health Partners Announces Nasdaq’s Confirmation that it has Regained Compliance with Listing Requirements P3 Health Partners Provides Second-Quarter and Year-to-Date 2022 Financial Results; Increases 2022 Revenue Outlook P3 Health Partners Announces Chief Financial Officer Transition Appoints Erin Darakjian as Interim CFO P3 Health Partners to Present 1H 2022 Financial Results P3 Health Partners Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal P3 Health Partners CEO Dr. Sherif Abdou to Speak at Nephron 2nd Annual Physician Enablement Symposium P3 Arizona Announces New Medical Clinic in Cochise County, Arizona Allen Pate to Lead P3 Nevada Operations P3 Health Partners Expands its Footprint in Nevada P3 Health Partners Fireside Chat Hosted by LifeSci Advisors, LLC P3 Health Partners Nevada Joins Humana Medicare Advantage Network P3 Health Partners CEO Dr. Sherif Abdou Featured on Benchtop Bios Podcast P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Report Oregon State Athletics, P3 Health Partners Oregon Announce Multi-Year Relationship P3 Health Partners Announces Inclusion in the Russell 3000® Index P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Reports P3 Health Partners to Present Fourth Quarter and Full Year 2021 Financial Results P3 Health Partners Announces Select Preliminary Fourth Quarter and Full Year 2021 Results, and Introduces 2022 Outlook P3 Health Partners to Participate at Upcoming Investor Conferences P3 Health Partners Expands to California, Closes Acquisition of Medcore HP and Omni IPA Medical Group, Inc. P3 Health Partners Announces Participation at the 40th Annual J.P. Morgan Healthcare Conference P3 Health Partners Closes Business Combination with Foresight Acquisition Corp. and Will Begin Trading on the Nasdaq